GeneralConnection.com ➔ Dictionary
Dictionary Search

haemophilia a

Synonyms

Noun

1. hemophilia A

2. haemophilia A, classical hemophilia, classical haemophilia, hemophilia, haemophilia, bleeder's disease

Usage
Real-World Use of Efanesoctocog Alfa Shows Benefit in Severe Hemophilia A - Hematology Advisor
Raising the bar in haemophilia A care - Roche
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B | New England Journal of Medicine - The New England Journal of Medicine
Journeying Towards Excellence in the Care of Patients with Haemophilia | JBM - Dove Medical Press
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials - Nature
Novo Nordisk submits Biologics License Application (BLA) to FDA for Mim8; an investigational, prophylaxis treatment for people living with hemophilia A with or without inhibitors - PR Newswire
JEADV Clinical Practice | Clinical Dermatology and Venereology Journal - Wiley Online Library
Marstacimab Superior to On-Demand Prophylaxis for Hemophilia A, B, With Inhibitors - Docwire News
Geneventiv notes FDA ‘positive’ feedback on hemophilia A therapy - Hemophilia News Today
Karnataka Government Unveils Launches Kusuma Sanjeevini Programme For Haemophilia Patients - BW Healthcare World
Pfizer’s Hympavzi significantly reduces bleeds in haemophilia patients - PMLiVE
Sobi to Showcase Scientific advances and Commitment to the Haemophilia community at EAHAD 2026 - Yahoo Finance
Redefining Hemophilia Management: Treatment Goals, Nonfactor Replacement Therapies, and the Role of Fitusiran - AJMC
EAHAD 2026: Bone Loss Risk Reduced by Early Haemophilia Prophylaxis - European Medical Journal
Assessing stigma in a predominantly male hemophilia population: a Chinese cross-sectional study - Frontiers
Enhancing Engagement to Support Shared Decision Making Within Haemophilia: Development of Materials for People With Haemophilia, Caregivers and Healthcare Professionals - Wiley Online Library
Standard or low-dose rituximab effective for acquired hemophilia A - Hemophilia News Today
FDA Supports Advancement of GENV-HEM Gene Therapy for Hemophilia A - Docwire News
Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study - The New England Journal of Medicine
Hemlibra may help active men with hemophilia A stay in the game - Hemophilia News Today
Novo Nordisk’s Alhemo approved by FDA for expanded haemophilia use - PMLiVE
EnzySystem for hemophilia A could make home clotting tests easier - Hemophilia News Today
Progressive cephalohematoma in a neonate revealing severe hemophilia a owing to intron 22 inversion: a case report - Frontiers
FDA expands approvals for Novartis lipid drug, Novo haemophilia prophylatic - FirstWord Pharma
BioMarin, following sluggish sales, to offload hemophilia gene therapy - BioPharma Dive
NICE Recommends First Subcutaneous Option for Haemophilia B - Medscape
Breaking sex biases: access for all in haemophilia care - The Lancet
Hull teenager first to be treated with new haemophilia drug - BBC
European Medicines Agency Issues Positive Opinion for Concizumab Label Update in Hemophilia - Docwire News
Nonfactor Therapies for Hemophilia: Current Evidence, Clinical Relevance and Cost Considerations - Managed Healthcare Executive
UK Approves Marstacimab for Severe Haemophilia A or B - Medscape
Distribution of people with bleeding disorders worldwide in 2024, by gender - Statista
Early diagnosis reduces treatment burden in hemophilia A children - Hemophilia News Today
Pfizer Reports Patient Death in Long-Term Trial of Hympavzi for Hemophilia A - BioSpace
Number of people with bleeding disorders worldwide in 2024, by condition - Statista
Pfizer reports positive results from Phase III BASIS trial for haemophilia - Clinical Trials Arena
EVOLVING THE TREATMENT LANDSCAPE WITH THE FIRST THERAPY APPROVED FOR PEOPLE WITH HEMOPHILIA A AND B WITH OR WITHOUT INHIBITORS - AJMC
Pfizer sets up Hympavzi expansion into haemophilia A or B with inhibitors - FirstWord Pharma
Pfizer shares positive phase 3 results for haemophilia A and B therapy Hympavzi - PMLiVE
NICE recommends weekly injection for severe haemophilia B - The Pharmaceutical Journal
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors - Business Wire
Spotlight On: Hemlibra holds steady amid changing haemophilia A market - FirstWord Pharma
NHS broadens access to haemophilia A drug Hemlibra - pharmaphorum
Early data suggest Roche’s NXT007 may have the potential to - GlobeNewswire
Roche's Hemlibra follow-up set for phase 3 in haemophilia A - pharmaphorum
Haemophilia gene therapy patients thriving over a decade after treatment - University College London
Your Blood Donation Story Has the Power to Save Lives – Share It - Good Things Guy
Six biotech companies leading the charge in hemophilia treatment - Labiotech.eu
Re-evaluating European Haemophilia Standards: Towards a More Inclusive Global Framework - European Medical Journal
Roche unveils promising Phase 1/2 results for NXT007 in haemophilia A - World Pharmaceutical Frontiers
Advances in hemophilia treatment | Windyga | Acta Haematologica Polonica - Via Medica Journals
Veterinarian aims to bring hemophilia treatment to pet dogs - Veterinary Information Network®, Inc. - VIN
Half of Severe Hemophilia A Cases Have No Family History, Delaying Diagnosis but Not Raising Inhibitor Risk - Managed Healthcare Executive
Sanofi lends support to ‘Dismissed’ film about 5 women’s experiences with hemophilia - Fierce Pharma
Alhemo Indication Expanded to Include Hemophilia A/B Without Inhibitors - MPR - Medical Professionals Reference
Pfizer confirms patient death in Hympavzi hemophilia extension study - Fierce Pharma
Invited Medical Presentation Abstracts - 2025 - Haemophilia - Wiley Online Library
Karnataka launches ‘Kusuma Sanjeevini’ to provide free preventive treatment for haemophilia patients at 3 - The Times of India
Sanofi’s Qfitlia approved by FDA as first haemophilia therapy for all patients - Pharmaceutical Technology
Discovery could improve treatment for people with hemophilia A - Medical Xpress
Entering a New Era in Protection in Haemophilia A - European Medical Journal
Pfizer’s Hympavzi granted MHRA approval to treat haemophilia A and B - PMLiVE
Final guidance issued for Altuvoct as severe hemophilia A treatment - Hemophilia News Today
Preventing bleeds before they happen: understanding prophylaxis in haemophilia care - The Hindu
Efficacy of extended half-life factor VIII concentrate (Elocta) compared to standard half-life factor VIII products in patients with severe hemophilia A — impact on treatment adherence and patient preferences | Zdziarska | Acta Haematologica Polonica - Via Medica Journals
Parliament petitioned to address high costs, specialised treatment for haemophilia patients - The Eastleigh Voice
FDA Approves Jivi for Pediatric Patients Aged 7 to 12 Years With Hemophilia A - AJMC
Pfizer hemophilia drug could become first non-factor option for kids 6-11 - Stock Titan
100 Years of von Willebrand Disease - European Medical Journal
Pfizer's weekly haemophilia drug backed for NHS use - pharmaphorum
K'taka launches ‘Kusuma Sanjeevini’ scheme to provide free preventive care for haemophilia patients | Bengaluru - Hindustan Times
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia A | Genes & Immunity - Nature
FDA clears Sanofi's siRNA as first rebalancing agent for all haemophilia patients - FirstWord Pharma
Acquired hemophilia A in a patient with small lymphocytic lymphoma and SARS-CoV-2 infection - Via Medica Journals
Novo Nordisk presents promising findings for haemophilia treatment - Pharmafile
Multifactorial assessment of cardiovascular risk in patients with severe hemophilia from the lower Silesia region in Poland | Podolak-Dawidziak | Acta Haematologica Polonica - Via Medica Journals
Review of the 18th Annual Congress of the European Association for Haemophilia and Allied Disorders - European Medical Journal
Sanofi’s Qfitlia granted FDA approval to treat haemophilia A or B - PMLiVE
International recommendations on the diagnosis and treatment of acquired hemophilia A - Haematologica
Genentech pays tribute to moms of children with hemophilia A in Hemlibra short film - Fierce Pharma
Caplin Steriles gets FDA approval for desmopressin - Indian Pharma Post
Haemophilia patients face shortage of clotting injections at MKCG - The Times of India
Haemophilia - The Lancet
CDC Hemophilia Mutation Projects (CHAMP and CHBMP) - Centers for Disease Control and Prevention | CDC (.gov)
Recommendations of Expert Group of Polish Society of Pediatric Oncology and Hematology on use of immune tolerance induction (ITI) in pediatric patients with hemophilia A complicated by a factor VIII inhibitor | Wojdalska | Acta Haematologica Polonica - Via Medica Journals
Get easily bruised? It may be due to haemophilia B - Healthshots
Haemophilia A in infants - Roche
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A - The New England Journal of Medicine
Govt considers low-dose emicizumab for haemophilia, trial finds it more effective than existing treatment - ThePrint
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A | New England Journal of Medicine - The New England Journal of Medicine
Novo Nordisk’s haemophilia A drug stops bleeds in 74% of children - Clinical Trials Arena
Anti-CD19 CAR-T cell therapy for acquired hemophilia A - Leukemia - Nature
Gene Therapy: The New Frontier in Haemophilia Treatment ​ - European Medical Journal
Rare within rare: Women with haemophilia - Roche
Qfitlia approved by FDA to treat haemophilia A or B - Pharmafile
AAV5–Factor VIII Gene Transfer in Severe Hemophilia A | New England Journal of Medicine - The New England Journal of Medicine
Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study - The Lancet
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study - The Lancet
Tailoring the effect of antithrombin-targeting therapy in haemophilia A using in silico thrombin generation - Nature
Inhibitor Eradication in Postpartum Acquired Haemophilia A: Real-Life Case Series and Literature Review - Wiley Online Library
Foreign Language Equivalents
Foreign Language Equivalents of 'haemophilia a'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
haemophulia a,   haemophiliaa ,   haemophilis a,   haemophiliia a,   haemohpilia a,   haemophila a,   haeophilia a,   haemopihlia a,   haemophilua a,   aemophilia a,   gaemophilia a,   haemophilia ,   haenophilia a,   haemophikia a,   hsemophilia a,   harmophilia a,   haemopilia a,   haemophili a,   jaemophilia a,   haaemophilia a,   haeomphilia a,   haemopholia a,   haemmophilia a,   haemoophilia a,   hemophilia a,   haemophili aa,   haemophlia a,   haemophiliaa a,   haempphilia a,   haemopjilia a,   hameophilia a,   haemohilia a,   haemopgilia a,   haemo[hilia a,   haemiphilia a,   hawmophilia a,   haemophillia a,   haeemophilia a,   haemophiliaa,   hae,ophilia a,   haemophilia aa,   haemophiilia a,   haemophliia a,   hamophilia a,   haemophilai a,   hhaemophilia a,   haemophiloa a,   haemophilia s,   haemoohilia a,   haemopphilia a,   haempohilia a,   heamophilia a,   haemophiila a,   haemophi;ia a,   ahemophilia a,   haemophhilia a,   haemophilia a,   haemophiia a,   haemphilia a
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z